Back
Vicapsys Life Sciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
77
VICP
Vicapsys Life Sciences
Last Price:
7.0000
Seasonality Move:
-1.07%
Sell
16
NBY
NovaBay Pharmaceuticals
Last Price:
0.54
Seasonality Move:
-8.54%
Buy
77
Vicapsys Life Sciences (VICP)
is a Buy
Is Vicapsys Life Sciences a Buy, Sell or Hold?
- The current Vicapsys Life Sciences [VICP] share price is $7.0000. The Score for VICP is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- VICP is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
VICP Stock Price Chart
What is Vicapsys Life Sciences's stock price today?
-
The Vicapsys Life Sciences share price today is $7.0000
The current trend is relatively stagnant and VICP is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
VICP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 77.57 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 32.51 | Sell |
Chaikin Money Flow: | -111892 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.58 - 0.72) | Sell |
Bollinger Bands (100): | (0.35 - 0.97) | Sell |
VICP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7 | Sell |
20-day SMA: | 7 | Sell |
50-day SMA: | 7 | Sell |
200-day SMA: | 4.53 | Buy |
8-day EMA: | 7 | Sell |
20-day EMA: | 7 | Buy |
50-day EMA: | 6.94 | Buy |
200-day EMA: | 5.22 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.58 | Sell |
20-day SMA: | 0.64 | Sell |
50-day SMA: | 0.65 | Sell |
200-day SMA: | 2.04 | Sell |
8-day EMA: | 0.58 | Sell |
20-day EMA: | 0.62 | Sell |
50-day EMA: | 0.68 | Sell |
200-day EMA: | 5 | Sell |
Vicapsys Life Sciences Earnings Growth & VICP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Vicapsys Life Sciences Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |